These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 9112289

  • 1. Lipoxins and novel aspirin-triggered 15-epi-lipoxins (ATL): a jungle of cell-cell interactions or a therapeutic opportunity?
    Serhan CN.
    Prostaglandins; 1997 Feb; 53(2):107-37. PubMed ID: 9112289
    [Abstract] [Full Text] [Related]

  • 2. Lipoxin and aspirin-triggered 15-epi-lipoxin cellular interactions anti-inflammatory lipid mediators.
    Serhan CN, Takano T, Gronert K, Chiang N, Clish CB.
    Clin Chem Lab Med; 1999 Mar; 37(3):299-309. PubMed ID: 10353476
    [Abstract] [Full Text] [Related]

  • 3. Lipoxins, aspirin-triggered 15-epi-lipoxin stable analogs and their receptors in anti-inflammation: a window for therapeutic opportunity.
    Serhan CN, Levy BD, Clish CB, Gronert K, Chiang N.
    Ernst Schering Res Found Workshop; 2000 Mar; (31):143-85. PubMed ID: 10943332
    [Abstract] [Full Text] [Related]

  • 4. Lipoxins and aspirin-triggered 15-epi-lipoxin biosynthesis: an update and role in anti-inflammation and pro-resolution.
    Serhan CN.
    Prostaglandins Other Lipid Mediat; 2002 Aug; 68-69():433-55. PubMed ID: 12432935
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution.
    Serhan CN.
    Prostaglandins Leukot Essent Fatty Acids; 2005 Aug; 73(3-4):141-62. PubMed ID: 16005201
    [Abstract] [Full Text] [Related]

  • 7. Neutrophil-mediated changes in vascular permeability are inhibited by topical application of aspirin-triggered 15-epi-lipoxin A4 and novel lipoxin B4 stable analogues.
    Takano T, Clish CB, Gronert K, Petasis N, Serhan CN.
    J Clin Invest; 1998 Feb 15; 101(4):819-26. PubMed ID: 9466977
    [Abstract] [Full Text] [Related]

  • 8. Lipoxins and aspirin-triggered 15-epi-lipoxins are endogenous components of antiinflammation: emergence of the counterregulatory side.
    Serhan CN.
    Arch Immunol Ther Exp (Warsz); 2001 Feb 15; 49(3):177-88. PubMed ID: 11478391
    [Abstract] [Full Text] [Related]

  • 9. Aspirin-triggered 15-epi-lipoxin A4 (LXA4) and LXA4 stable analogues are potent inhibitors of acute inflammation: evidence for anti-inflammatory receptors.
    Takano T, Fiore S, Maddox JF, Brady HR, Petasis NA, Serhan CN.
    J Exp Med; 1997 May 05; 185(9):1693-704. PubMed ID: 9151906
    [Abstract] [Full Text] [Related]

  • 10. Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit human neutrophil migration: comparisons between synthetic 15 epimers in chemotaxis and transmigration with microvessel endothelial cells and epithelial cells.
    Fierro IM, Colgan SP, Bernasconi G, Petasis NA, Clish CB, Arita M, Serhan CN.
    J Immunol; 2003 Mar 01; 170(5):2688-94. PubMed ID: 12594298
    [Abstract] [Full Text] [Related]

  • 11. Leukotriene B4 receptor transgenic mice reveal novel protective roles for lipoxins and aspirin-triggered lipoxins in reperfusion.
    Chiang N, Gronert K, Clish CB, O'Brien JA, Freeman MW, Serhan CN.
    J Clin Invest; 1999 Aug 01; 104(3):309-16. PubMed ID: 10430612
    [Abstract] [Full Text] [Related]

  • 12. Anti-inflammatory circuitry: lipoxin, aspirin-triggered lipoxins and their receptor ALX.
    Chiang N, Arita M, Serhan CN.
    Prostaglandins Leukot Essent Fatty Acids; 2005 Aug 01; 73(3-4):163-77. PubMed ID: 16125378
    [Abstract] [Full Text] [Related]

  • 13. Aspirin-triggered lipoxin A4 and B4 analogs block extracellular signal-regulated kinase-dependent TNF-alpha secretion from human T cells.
    Ariel A, Chiang N, Arita M, Petasis NA, Serhan CN.
    J Immunol; 2003 Jun 15; 170(12):6266-72. PubMed ID: 12794159
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Activation of lipoxin A(4) receptors by aspirin-triggered lipoxins and select peptides evokes ligand-specific responses in inflammation.
    Chiang N, Fierro IM, Gronert K, Serhan CN.
    J Exp Med; 2000 Apr 03; 191(7):1197-208. PubMed ID: 10748237
    [Abstract] [Full Text] [Related]

  • 16. Selectivity of recombinant human leukotriene D(4), leukotriene B(4), and lipoxin A(4) receptors with aspirin-triggered 15-epi-LXA(4) and regulation of vascular and inflammatory responses.
    Gronert K, Martinsson-Niskanen T, Ravasi S, Chiang N, Serhan CN.
    Am J Pathol; 2001 Jan 03; 158(1):3-9. PubMed ID: 11141472
    [Abstract] [Full Text] [Related]

  • 17. Novel lipid mediator regulators of endothelial cell proliferation and migration: aspirin-triggered-15R-lipoxin A(4) and lipoxin A(4).
    Fierro IM, Kutok JL, Serhan CN.
    J Pharmacol Exp Ther; 2002 Feb 03; 300(2):385-92. PubMed ID: 11805195
    [Abstract] [Full Text] [Related]

  • 18. Mechanisms in anti-inflammation and resolution: the role of lipoxins and aspirin-triggered lipoxins.
    Fierro IM, Serhan CN.
    Braz J Med Biol Res; 2001 May 03; 34(5):555-66. PubMed ID: 11323741
    [Abstract] [Full Text] [Related]

  • 19. Aspirin-triggered lipoxin A4 and lipoxin A4 up-regulate transcriptional corepressor NAB1 in human neutrophils.
    Qiu FH, Devchand PR, Wada K, Serhan CN.
    FASEB J; 2001 Dec 03; 15(14):2736-8. PubMed ID: 11687510
    [Abstract] [Full Text] [Related]

  • 20. Lipoxin receptors.
    Romano M, Recchia I, Recchiuti A.
    ScientificWorldJournal; 2007 Sep 01; 7():1393-412. PubMed ID: 17767357
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.